Revance Therapeutics, Inc. Announces Participation in Jefferies 2014 Global Healthcare Conference

May 21, 2014

NEWARK, Calif., May 21, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), today announced that its management is scheduled to participate in the Jefferies 2014 Global Healthcare Conference in New York.

Revance management is scheduled to present on Monday, June 2, 2014 at 8:00 am ET. Interested parties can access the live audio webcast for this conference presentation at The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.

About Revance Therapeutics, Inc.

Revance is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The Company is leveraging its proprietary portfolio of botulinum toxin compounds combined with its patented TransMTS® peptide delivery system to address unmet needs in the large and growing aesthetic and therapeutic botulinum toxin market. Revance's proprietary TransMTS technology enables transcutaneous delivery of botulinum toxin A, eliminating the need for injections.

CONTACT: Westwicke Partners

         Ana Petrovic

         (415) 513-1281